
doi: 10.1038/nrd.2018.89
pmid: 29904194
This article discusses the market for oral anticoagulants, and how therapies in development and antidotes to existing drugs could affect the therapeutic landscape.
Drug Industry, Atrial Fibrillation, Administration, Oral, Anticoagulants, Humans, Venous Thromboembolism
Drug Industry, Atrial Fibrillation, Administration, Oral, Anticoagulants, Humans, Venous Thromboembolism
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 17 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
